New York, NY -- (SBWIRE) -- 12/04/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: CytRx Corporation (NASDAQ:CYTR), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), Ballard Power Systems Inc. (USA) (NASDAQ:BLDP), Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
CytRx Corporation (NASDAQ:CYTR) jumped 11.02 percent to $2.62 today on traded volume of 1.69 million shares. The company’s shareholder Scott Bradford Patterson on Tuesday purchased 284,979 shares of CYTR stock at an average price of $2.44 each share. CytRx stock has a 52-week range of $1.79 to $3.65. The biopharmaceutical company has a market capitalization of $109.14 million.
What was the Moving Force behind CYTR On Bullish Run? Read This Research Report on CYTR
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) rose 4.49 percent to $6.28 today on traded volume of 1.35 million shares. The company recently said that it will host its Annual Meeting of Shareholders on 4th of December. The meeting will start at 9:00 am ET. OXBT shares are trading in the range of $6.05 to $6.93 in the current trading session. The company has a market capitalization of $34.41 million.
Will OXBT Continue To Move Higher? Find Out Here
Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) is currently trading at $1.40 on volume of 1.67 million shares. The 52-week range of the stock is $0.57 to $2.39. Ballard Power Systems is focused on the development, manufacturing and marketing of fuel cell products for a number of applications. The company has a market capitalization of $151.99 million.
How Should Investors Trade BLDP Now? Don’t Miss out a Special Trend Analysis
Navidea Biopharmaceuticals Inc (NYSEMKT:NAVB) rose 3.61 percent to $1.72 on traded volume of 973,940 shares. The 52-week range of the stock is $1.11 to $3.59. Navidea on Monday said that it will host an Analyst Science Day on Thursday from 8:30 AM to 11:30 AM. CEO Mark Pykett will provide update on Lymphoseek Injection and other programs of the company. NAVB has a market capitalization of $231.07 million.
Where NAVB is Headed Exactly? Find out in This Trend Analysis Reports
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)